Chargement en cours...
Factors associated with guideline-recommended KRAS testing in colorectal cancer patients: A population-based study
OBJECTIVES: Response to epidermal growth factor receptor inhibitors is poorer among Stage IV colorectal cancer (CRC) patients with KRAS mutations, thus KRAS testing is recommended prior to treatment. KRAS testing was collected by Surveillance, Epidemiology, and End Results (SEER) registries for 2010...
Enregistré dans:
| Publié dans: | Am J Clin Oncol |
|---|---|
| Auteurs principaux: | , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2017
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4591083/ https://ncbi.nlm.nih.gov/pubmed/25844824 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/COC.0000000000000191 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|